NRSN · NeuroSense Therapeutics Ltd. · Documents
Market Cap
$5.06M
Shares
1.90M
Volume · Oct 20
13.1K
Avg daily vol (25 sessions)
26.33K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 20-F | — | 2025-04-07 | 2024-12-31 | |
| 6-K | — | 2025-04-07 | — | |
| 6-K | — | 2025-03-27 | — | |
| 6-K | — | 2025-03-19 | — | |
| 6-K | — | 2025-02-19 | — | |
| 6-K | — | 2025-01-06 | — | |
| F-3 | — | 2024-12-26 | — | |
| 6-K | — | 2024-12-23 | — | |
| 6-K | — | 2024-12-18 | — | |
| 6-K | — | 2024-12-17 | — | |
| 6-K | — | 2024-12-11 | — | |
| F-3 | — | 2024-12-06 | — | |
| 6-K | — | 2024-12-04 | — | |
| 6-K | — | 2024-12-02 | — | |
| F-1 | — | 2024-11-19 | — | |
| 6-K | — | 2024-11-12 | — | |
| 6-K | — | 2024-10-31 | — | |
| 6-K | — | 2024-10-30 | — | |
| 6-K | — | 2024-10-28 | — | |
| 6-K | — | 2024-10-24 | — | |
| 6-K | — | 2024-10-15 | — | |
| 6-K | — | 2024-10-09 | — | |
| 6-K | — | 2024-09-30 | 2024-06-30 | |
| 6-K | — | 2024-09-24 | — | |
| 6-K | — | 2024-09-16 | — | |
| 6-K | — | 2024-09-09 | — | |
| 6-K | — | 2024-08-30 | — | |
| 6-K | — | 2024-08-28 | — | |
| 6-K | — | 2024-08-26 | — | |
| 6-K | — | 2024-08-16 | — | |
| 6-K | — | 2024-08-07 | — | |
| 6-K | — | 2024-08-01 | — | |
| 6-K | — | 2024-07-09 | — | |
| 6-K | — | 2024-07-03 | — | |
| 6-K | — | 2024-07-01 | — | |
| 6-K | — | 2024-06-27 | — | |
| 6-K | — | 2024-06-24 | — | |
| 6-K | — | 2024-06-21 | — | |
| 6-K | — | 2024-06-17 | 2023-12-31 | |
| 6-K | — | 2024-05-28 | — | |
| 6-K | — | 2024-05-23 | — | |
| F-1/A | — | 2024-05-20 | — | |
| 6-K | — | 2024-05-20 | — | |
| 6-K | — | 2024-05-14 | — | |
| F-1 | — | 2024-05-10 | — | |
| 6-K | — | 2024-05-07 | — | |
| 6-K | — | 2024-04-12 | — | |
| 6-K | — | 2024-04-10 | — | |
| 6-K | — | 2024-04-09 | — | |
| 6-K | — | 2024-04-05 | — |
Showing 51–100 of 194 filings